Concepedia

Mariëlle Eerdekens

ME

Statistics

Publications

69

Citations

7.3K

H-Index

44

Active since

1999

Affiliations

Johnson & Johnson (United States)(Current)

Janssen (Belgium)

Janssen (United States)

Johnson & Johnson (Sweden)

Bar-Ilan University

Mariëlle Eerdekens is an author at Johnson & Johnson (United States) specializing in psychopharmacology, pharmacotherapy, and antipsychotic pharmacotherapy.

ORCID

Publications per year

1999–2023

69

Publications

69

Long-Acting Injectable Risperidone: Efficacy and Safety of the First Long-Acting Atypical Antipsychotic

John M. Kane, Mariëlle Eerdekens, Jean‐Pierre Lindenmayer et al. · American Journal of Psychiatry · 2003 · 492 citations

, , +16

Risperidone and Haloperidol in First-Episode Psychosis: A Long-Term Randomized Trial

Nina R. Schooler, Jonathan Rabinowitz, Michael Davidson et al. · American Journal of Psychiatry · 2005 · 346 citations

, , +17

Treatment of schizophrenia with paliperidone extended-release tablets: A 6-week placebo-controlled trial☆

John M. Kane, F. Cañas, Michelle Kramer et al. · Schizophrenia Research · 2006 · 297 citations

, , +12

Treatment of Schizophrenia With Long-Acting Injectable Risperidone

W. Wolfgang Fleischhacker, Mariëlle Eerdekens, Keith Karcher et al. · The Journal of Clinical Psychiatry · 2003 · 289 citations

, , +17

Rapid Antimanic Effect of Risperidone Monotherapy: A 3-Week Multicenter, Double-Blind, Placebo-Controlled Trial

Robert M. A. Hirschfeld, Paul E. Keck, Michelle Kramer et al. · American Journal of Psychiatry · 2004 · 273 citations

, , +17

1–5 of 69